Semiconductors
Compare Stocks
2 / 10Stock Comparison
PLAB vs ACLS
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
PLAB vs ACLS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Semiconductors | Semiconductors |
| Market Cap | $2.90B | $4.88B |
| Revenue (TTM) | $862M | $845M |
| Net Income (TTM) | $136M | $101M |
| Gross Margin | 35.1% | 43.6% |
| Operating Margin | 24.5% | 11.6% |
| Forward P/E | 22.3x | 43.5x |
| Total Debt | $24K | $42M |
| Cash & Equiv. | $492M | $145M |
PLAB vs ACLS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Photronics, Inc. (PLAB) | 100 | 420.0 | +320.0% |
| Axcelis Technologie… (ACLS) | 100 | 590.9 | +490.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PLAB vs ACLS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PLAB has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- Dividend streak 0 yrs, beta 2.88
- Rev growth -2.0%, EPS growth 9.1%, 3Y rev CAGR 1.0%
- Lower volatility, beta 2.88, Low D/E 0.0%, current ratio 5.37x
ACLS is the clearest fit if your priority is long-term compounding and defensive.
- 15.1% 10Y total return vs PLAB's 390.1%
- Beta 2.00, current ratio 4.77x
- Beta 2.00 vs PLAB's 2.88
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -2.0% revenue growth vs ACLS's -17.6% | |
| Value | Lower P/E (22.3x vs 43.5x), PEG 0.65 vs 2.06 | |
| Quality / Margins | 15.8% margin vs ACLS's 11.9% | |
| Stability / Safety | Beta 2.00 vs PLAB's 2.88 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +173.2% vs PLAB's +165.2% | |
| Efficiency (ROA) | 7.5% ROA vs PLAB's 7.2%, ROIC 9.6% vs 15.5% |
PLAB vs ACLS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PLAB vs ACLS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PLAB leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PLAB and ACLS operate at a comparable scale, with $862M and $845M in trailing revenue. Profitability is closely matched — net margins range from 15.8% (PLAB) to 11.9% (ACLS).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $862M | $845M |
| EBITDAEarnings before interest/tax | $287M | $111M |
| Net IncomeAfter-tax profit | $136M | $101M |
| Free Cash FlowCash after capex | $66M | $90M |
| Gross MarginGross profit ÷ Revenue | +35.1% | +43.6% |
| Operating MarginEBIT ÷ Revenue | +24.5% | +11.6% |
| Net MarginNet income ÷ Revenue | +15.8% | +11.9% |
| FCF MarginFCF ÷ Revenue | +7.6% | +10.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.1% | +3.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +8.8% | -65.9% |
Valuation Metrics
PLAB leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 22.1x trailing earnings, PLAB trades at a 47% valuation discount to ACLS's 41.8x P/E. Adjusting for growth (PEG ratio), PLAB offers better value at 0.64x vs ACLS's 1.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.9B | $4.9B |
| Enterprise ValueMkt cap + debt − cash | $2.4B | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | 22.09x | 41.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.32x | 43.49x |
| PEG RatioP/E ÷ EPS growth rate | 0.64x | 1.98x |
| EV / EBITDAEnterprise value multiple | 8.43x | 34.85x |
| Price / SalesMarket cap ÷ Revenue | 3.42x | 5.81x |
| Price / BookPrice ÷ Book value/share | 1.89x | 4.86x |
| Price / FCFMarket cap ÷ FCF | 48.65x | 45.56x |
Profitability & Efficiency
PLAB leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ACLS delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $8 for PLAB. PLAB carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACLS's 0.04x. On the Piotroski fundamental quality scale (0–9), PLAB scores 6/9 vs ACLS's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.3% | +9.8% |
| ROA (TTM)Return on assets | +7.2% | +7.5% |
| ROICReturn on invested capital | +15.5% | +9.6% |
| ROCEReturn on capital employed | +13.1% | +10.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.00x | 0.04x |
| Net DebtTotal debt minus cash | -$492M | -$103M |
| Cash & Equiv.Liquid assets | $492M | $145M |
| Total DebtShort + long-term debt | $24,000 | $42M |
| Interest CoverageEBIT ÷ Interest expense | 3777.78x | 77.10x |
Total Returns (Dividends Reinvested)
ACLS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACLS five years ago would be worth $38,679 today (with dividends reinvested), compared to $38,152 for PLAB. Over the past 12 months, ACLS leads with a +173.2% total return vs PLAB's +165.2%. The 3-year compound annual growth rate (CAGR) favors PLAB at 50.3% vs ACLS's 9.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +50.7% | +84.2% |
| 1-Year ReturnPast 12 months | +165.2% | +173.2% |
| 3-Year ReturnCumulative with dividends | +239.4% | +32.2% |
| 5-Year ReturnCumulative with dividends | +281.5% | +286.8% |
| 10-Year ReturnCumulative with dividends | +390.1% | +1505.9% |
| CAGR (3Y)Annualised 3-year return | +50.3% | +9.7% |
Risk & Volatility
Evenly matched — PLAB and ACLS each lead in 1 of 2 comparable metrics.
Risk & Volatility
ACLS is the less volatile stock with a 2.00 beta — it tends to amplify market swings less than PLAB's 2.88 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.88x | 2.00x |
| 52-Week HighHighest price in past year | $53.00 | $171.60 |
| 52-Week LowLowest price in past year | $16.59 | $55.81 |
| % of 52W HighCurrent price vs 52-week peak | +95.0% | +92.5% |
| RSI (14)Momentum oscillator 0–100 | 67.5 | 84.4 |
| Avg Volume (50D)Average daily shares traded | 865K | 734K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates PLAB as "Buy" and ACLS as "Buy". Consensus price targets imply -2.0% upside for PLAB (target: $49) vs -19.3% for ACLS (target: $128).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $49.33 | $128.00 |
| # AnalystsCovering analysts | 11 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +2.5% |
PLAB leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). ACLS leads in 1 (Total Returns). 1 tied.
PLAB vs ACLS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is PLAB or ACLS a better buy right now?
For growth investors, Photronics, Inc.
(PLAB) is the stronger pick with -2. 0% revenue growth year-over-year, versus -17. 6% for Axcelis Technologies, Inc. (ACLS). Photronics, Inc. (PLAB) offers the better valuation at 22. 1x trailing P/E (22. 3x forward), making it the more compelling value choice. Analysts rate Photronics, Inc. (PLAB) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PLAB or ACLS?
On trailing P/E, Photronics, Inc.
(PLAB) is the cheapest at 22. 1x versus Axcelis Technologies, Inc. at 41. 8x. On forward P/E, Photronics, Inc. is actually cheaper at 22. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Photronics, Inc. wins at 0. 65x versus Axcelis Technologies, Inc. 's 2. 06x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PLAB or ACLS?
Over the past 5 years, Axcelis Technologies, Inc.
(ACLS) delivered a total return of +286. 8%, compared to +281. 5% for Photronics, Inc. (PLAB). Over 10 years, the gap is even starker: ACLS returned +1506% versus PLAB's +390. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PLAB or ACLS?
By beta (market sensitivity over 5 years), Axcelis Technologies, Inc.
(ACLS) is the lower-risk stock at 2. 00β versus Photronics, Inc. 's 2. 88β — meaning PLAB is approximately 44% more volatile than ACLS relative to the S&P 500. On balance sheet safety, Photronics, Inc. (PLAB) carries a lower debt/equity ratio of 0% versus 4% for Axcelis Technologies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PLAB or ACLS?
By revenue growth (latest reported year), Photronics, Inc.
(PLAB) is pulling ahead at -2. 0% versus -17. 6% for Axcelis Technologies, Inc. (ACLS). On earnings-per-share growth, the picture is similar: Photronics, Inc. grew EPS 9. 1% year-over-year, compared to -38. 2% for Axcelis Technologies, Inc.. Over a 3-year CAGR, PLAB leads at 1. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PLAB or ACLS?
Photronics, Inc.
(PLAB) is the more profitable company, earning 16. 1% net margin versus 14. 3% for Axcelis Technologies, Inc. — meaning it keeps 16. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLAB leads at 24. 5% versus 14. 2% for ACLS. At the gross margin level — before operating expenses — ACLS leads at 44. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PLAB or ACLS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Photronics, Inc. (PLAB) is the more undervalued stock at a PEG of 0. 65x versus Axcelis Technologies, Inc. 's 2. 06x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Photronics, Inc. (PLAB) trades at 22. 3x forward P/E versus 43. 5x for Axcelis Technologies, Inc. — 21. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PLAB: -2. 0% to $49. 33.
08Which pays a better dividend — PLAB or ACLS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is PLAB or ACLS better for a retirement portfolio?
For long-horizon retirement investors, Axcelis Technologies, Inc.
(ACLS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1506% 10Y return). Photronics, Inc. (PLAB) carries a higher beta of 2. 88 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACLS: +1506%, PLAB: +390. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PLAB and ACLS?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.